The biggest concern facing Pharmaceutical industry CME professionals is how to prove their value within their companies, a proposition that's becoming much more difficult because of the increasing government scrutiny of commercially-supported CME, according to the results of a survey of attendees at the Pharmaceutical Alliance for CME member section meeting. The meeting was convened during the Alliance for CME annual conference in Orlando, held January 19 to 22, which attracted a record ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Proving CME's Value, you'll get exclusive access to a large archive of premium content.

Already registered? here.